Showing results (841-850 of 5,688) with videos related to

Sort By:
Pageof 569
The Oncologist|December 2, 2015
Age and Gender Moderate the Impact of Early Palliative Care in Metastatic Non-Small Cell Lung CancerRyan D Nipp, Joseph A Greer, Areej El-Jawahri, et al.
The Oncologist|November 29, 2015
Use of Palliative Care Services in a Tertiary Cancer CenterShalini Dalal, Sebastian Bruera, David Hui, et al.
The Oncologist|October 10, 2013
What lies within: novel strategies in immunotherapy for non-small cell lung cancerPatrick M Forde, Kim A Reiss, Amer M Zeidan, et al.
The Oncologist|October 10, 2013
A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphomaAndré Bosly, Andrew Grigg, Harald Holte, et al.
The Oncologist|October 10, 2013
A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathyMario Campone, Dominique Berton-Rigaud, Florence Joly-Lobbedez, et al.
The Oncologist|August 22, 2014
How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancerChristina Kim, Karen Mulder, Jennifer Spratlin
The Oncologist|August 22, 2014
Phase I study of sunitinib in combination with gemcitabine and capecitabine for first-line treatment of metastatic or unresectable renal cell carcinomaJoaquim Bellmunt, Cristina Suarez, Enrique Gallardo, et al.
The Oncologist|December 10, 2013
Prediction of postchemotherapy ovarian function using markers of ovarian reserveN Lynn Henry, Rong Xia, Anne F Schott, et al.
The Oncologist|January 21, 2015
Dose-dense nonpegylated liposomal Doxorubicin and docetaxel combination in breast cancer: dose-finding studyEnrico Ricevuto, Valentina Cocciolone, Maria Mancini, et al.
The Oncologist|March 31, 2016
FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1Joohee Sul, Gideon M Blumenthal, Xiaoping Jiang, et al.
Pageof 569